Zobrazeno 41 - 43
of 43
pro vyhledávání: '"Yao, Lijing"'
Autor:
Xu J; Department of Radiotherapy, The First Hospital of Putian City, Putian, Fujian 351100, China., Chen R; Department of Radiotherapy, The First Hospital of Putian City, Putian, Fujian 351100, China., Yang Y; Department of Radiotherapy, The First Hospital of Putian City, Putian, Fujian 351100, China., Xu S; Department of Proctology of Traditional Chinese Medicine, The First Hospital of Putian City, Putian, Fujian 351100, China., Yao L; Department of Radiotherapy, The First Hospital of Putian City, Putian, Fujian 351100, China.
Publikováno v:
Aging [Aging (Albany NY)] 2024 Jun 13; Vol. 16 (12), pp. 10366-10379. Date of Electronic Publication: 2024 Jun 13.
Autor:
Lau B; HypaHealth, HypaHub Inc., San Jose, CA 95128, USA., Emani PS; Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA.; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA., Chapman J; Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA.; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA., Yao L; HypaHealth, HypaHub Inc., San Jose, CA 95128, USA., Lam T; HypaHealth, HypaHub Inc., San Jose, CA 95128, USA., Merrill P; HypaHealth, HypaHub Inc., San Jose, CA 95128, USA., Warrell J; Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA.; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA., Gerstein MB; Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA.; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA.; Department of Computer Science, Yale University, New Haven, CT 06520, USA.; Department of Statistics & Data Science, Yale University, New Haven, CT 06520, USA., Lam HYK; HypaHealth, HypaHub Inc., San Jose, CA 95128, USA.
Publikováno v:
Bioinformatics (Oxford, England) [Bioinformatics] 2023 Jan 01; Vol. 39 (1).
Autor:
Max Ma X; Medical Scientific Affairs, Roche Sequencing Solutions, Inc., Pleasanton, California. xiaoju.ma@gmail.com john.palma@roche.com., Bendell JC; Drug Development Unit, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee., Hurwitz HI; Project Development Oncology, Genentech, Inc., South San Francisco, California., Ju C; Clinical Operations and Biometrics, Roche Molecular Systems, Pleasanton, California., Lee JJ; Medical Scientific Affairs, Roche Sequencing Solutions, Inc., Pleasanton, California., Lovejoy A; Assay Development, Roche Sequencing Solutions, Inc., Pleasanton, California., Mancao C; Oncology Biomarker Development, Genentech, Inc., Basel, Switzerland., Nicholas A; US Medical Affairs and Biometrics, Genentech, Inc., South San Francisco, California., Price R; Oncology Biomarker Development, Genentech, Inc., Basel, Switzerland., Sommer N; Medical Affairs BioOncology, Genentech, Inc., South San Francisco, California., Tikoo N; Clinical Operations and Biometrics, Roche Molecular Systems, Pleasanton, California., Yao L; Bioinformatics Research and Early Development, Roche Sequencing Solutions, Inc., Pleasanton, California., Yaung SJ; Medical and Scientific Affairs Bioinformatics, Roche Sequencing Solutions, Inc., Pleasanton, California., Palma JF; Medical Scientific Affairs, Roche Sequencing Solutions, Inc., Pleasanton, California. xiaoju.ma@gmail.com john.palma@roche.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Aug 01; Vol. 26 (15), pp. 4010-4017. Date of Electronic Publication: 2020 Mar 27.